Side effect management during immune checkpoint blockade using CTLA‐4 and PD‐1 antibodies for metastatic melanoma – an update
2020 ◽
Vol 18
(6)
◽
pp. 582-609
Keyword(s):
Keyword(s):
2020 ◽
2016 ◽
Vol 66
(1)
◽
pp. 113-117
◽
Keyword(s):
2016 ◽
Vol 14
(7)
◽
pp. 662-681
◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. 3026-3026
◽